Cyclo(Phe-Pro)

CAS No. 14705-60-3

Cyclo(Phe-Pro)( Cyclo(phenylalanylprolyl) | A-64863 )

Catalog No. M23630 CAS No. 14705-60-3

Cyclo(Phe-Pro) known as a secondary metabolite of some bacteria and fungi, is also produced by Vibrio vulnificus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
5MG 37 In Stock
10MG 61 In Stock
25MG 109 In Stock
50MG 183 In Stock
100MG 291 In Stock
200MG 435 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cyclo(Phe-Pro)
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyclo(Phe-Pro) known as a secondary metabolite of some bacteria and fungi, is also produced by Vibrio vulnificus.
  • Description
    Cyclo(Phe-Pro) known as a secondary metabolite of some bacteria and fungi, is also produced by Vibrio vulnificus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cyclo(phenylalanylprolyl) | A-64863
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14705-60-3
  • Formula Weight
    244.29
  • Molecular Formula
    C14H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (511.69 mM; Need ultrasonic)
  • SMILES
    C1CC2C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lee W, et al. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity. Nat Commun. 2018 Apr 23;9(1):1606.
molnova catalog
related products
  • Cromoglicic acid

    Cromoglicic acid is a mast cell stabilizer with anti-inflammatory activity that prevents the release of inflammatory chemicals such as histamine, leukotrienes from mast cells.

  • Dyngo-4a

    Dyngo-4a , a effective dynamin inhibitor, inhibits withDynI (brain), DynI (rec), and DynII (rec) of IC50 of 0.38 μM, 1.1 μM, and 2.3 μM, respectively.

  • Araloside X

    Aralosides possess protective effect against experimental myocardial ischemia and infarction, the mechanism of myocardial protection may be attributed to the amelioration of FFA metabolic deterioration and membrane peroxidation induced by oxygen free radicals. Aralosides have anti-inflammatory effect, they also can effectively prevent acute alcoholic liver injury.